secwatch / observer
8-K filed March 10, 2026, 7:59 PM ET ticker LIXT CIK 0001335105
M&A confidence high sentiment neutral materiality 0.65

Lixte restructures Liora acquisition; issues 700k shares, $440k cash, Bitcoin/Ethereum for 80% stake

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

LIXTE BIOTECHNOLOGY HOLDINGS, INC. amended Amended and Restated Share Exchange Agreement with Orbit Capital Inc. valued at Amends and restates the Share Exchange Agreement dated November 21, 2025 (effective 2025-11-21).

Action
amendment
Agreement
equity purchase
Counterparty
Orbit Capital Inc.
Value
Amends and restates the Share Exchange Agreement dated November 21, 2025
Effective
2025-11-21
Exact text from the filing
On March 6, 2026, Lixte Biotechnology Holdings, Inc., (the “Company”), Liora Technologies Europe Ltd, a subsidiary of the Company (“Liora”) and Orbit Capital Inc., (“Orbit”), entered into an Amended and Restated Share Exchange Agreement with an effective date of November 21, 2025 (the A&R Agreement).
View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001493152-26-009526
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.